ACCORD BIOPHARMA, INC.

ACCORD BIOPHARMA

A full line of medicated and pharmaceutical preparations, for use in connection with humans;Providing healthcare and medical information; healthcare services, namely, providing information in the fields of Oncology, Immunology and Critical Care;

ACCORDCARES

ACCORD CARES;Providing health and healthcare information to consumers and other participants in the healthcare industry via a global computer network; providing an internet website portal in the field of health and healthcare information;Providing on-line, non-downloadable, Internet-based software applications for providing, exchanging, retrieving and analyzing health and healthcare information; providing a website featuring technology enabling users to exchange, retrieve and analyze health and healthcare information;

ACCORDCONNECTS

Downloadable computer software for use on mobile devices; Downloadable inventory management software; Downloadable computer programs used for managing inventories of pharmaceutical preparations;ACCORD CONNECTS;

AHNEU

Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production;

ENNUMO

Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production;

ENNUMO

Pharmaceutical preparations for stimulating white blood cell production;

FILKRI

Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell production;The wording FILKRI has no meaning in a foreign language.;

GRASTOFIL

In the statement, line 4, hemopoetic should be deleted, and hematopoietic should be inserted.;Pharmaceutical preparations for [hemopoetic] *hematopoietic* growth factors; pharamaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production;

GRAXOFIL

Biosimilar pharmaceutical preparation, namely, a granulocyte colony-stimulating factor analog used to stimulate the proliferation and differentiation of granulocytes for use with chemotherapy regimens to lessen the incidence of chemotherapy-induced neutropenia;

LAPELGA

Pharmaceutical preparations for hematopoietic growth factors; pharmaceutical preparations, namely, recombinant-human granulocyte-CSF for use in stimulating white blood cell production;

TAQNUE

Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplantation patients;